Caas Capital Management LP
- SEC CIK
- 0001802881
- Latest filing
- May 1, 2025
SLDB holding history
Solid Biosciences Inc. in every 13F filed by Caas Capital Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SLDB overviewAll 13F holders of SLDBFull Q1 2025 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −64,112−100.0% | Sold out | Holders |
| Q3 2023 | 64,112 | $161.6K | <0.1% | −37,569−36.9% | Reduced | Holders |
| Q2 2023 | 101,681 | $532.8K | 0.3% | −142,837−58.4% | Reduced | Holders |
| Q1 2023 | 244,518 | $1.16M | 0.4% | −39,169−13.8% | Reduced | Holders |
| Q4 2022 | 283,687 | $4.81M | 0.9% | +283,687 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −42,989−100.0% | Sold out | Holders |
| Q1 2021 | 42,989 | $238.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.